These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23374329)

  • 1. Challenges of providing maintenance hemodialysis in a resource poor country: Experience from a single teaching hospital in Lagos, Southwest Nigeria.
    Bello BT; Raji YR; Sanusi I; Braimoh RW; Amira OC; Mabayoje OM
    Hemodial Int; 2013 Jul; 17(3):427-33. PubMed ID: 23374329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and complications of permanent hemodialysis vascular access in Nigerians: a single centre experience.
    Alhassan SU; Adamu B; Abdu A; Aji SA
    Ann Afr Med; 2013; 12(2):127-30. PubMed ID: 23713021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hemodialysis in a Nigerian teaching hospital: practice and costs.
    Agaba EI; Lopez A; Ma I; Martinez R; Tzamaloukas RA; Vanderjagt DJ; Glew RH; Tzamaloukas AH
    Int J Artif Organs; 2003 Nov; 26(11):991-5. PubMed ID: 14708827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous alfacalcidol once versus twice or thrice weekly in hemodialysis patients.
    Alghareeb A; Sabry A; Bawadekji H; Alsaran K
    Ther Apher Dial; 2013 Feb; 17(1):30-4. PubMed ID: 23379490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of patients with end-stage renal disease on maintenance hemodialysis: a multicenter study in Iran.
    Beladi-Mousavi SS; Alemzadeh-Ansari MJ; Alemzadeh-Ansari MH; Beladi-Mousavi M
    Iran J Kidney Dis; 2012 Nov; 6(6):452-6. PubMed ID: 23146984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-stage renal disease patients on hemodialysis: a study from a tertiary care center in a developing country.
    Swarnalatha G; Ram R; Prasad N; Dakshinamurty KV
    Hemodial Int; 2011 Jul; 15(3):312-9. PubMed ID: 21518245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia and hypoalbuminemia at initiation of hemodialysis as risk factor for survival of dialysis patients.
    Anees M; Ibrahim M
    J Coll Physicians Surg Pak; 2009 Dec; 19(12):776-80. PubMed ID: 20042156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The viability of hemodialysis as a treatment option for renal failure in a developing economy.
    Arije A; Kadiri S; Akinkugbe OO
    Afr J Med Med Sci; 2000; 29(3-4):311-4. PubMed ID: 11714013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance dialysis in patients from developing countries: the experience of an Italian center.
    Fogazzi GB; Castelnovo C
    J Nephrol; 2004; 17(4):552-8. PubMed ID: 15372418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five years experience of haemodialysis at the Lagos University Teaching Hospital--November 1981 to November 1986.
    Odutola TA; Ositelu SB; D'Almeida EA; Mabadeje AF
    Afr J Med Med Sci; 1989 Sep; 18(3):193-201. PubMed ID: 2551160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of care assessment and adherence to the international guidelines considering dialysis, water treatment, and protection against transmission of infections in university hospital-based dialysis units in Cairo, Egypt.
    Ibrahim S
    Hemodial Int; 2010 Jan; 14(1):61-7. PubMed ID: 19758297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of intradialytic complications at the Lagos University Teaching Hospital.
    Amira CO; Braimoh RW; Bello BT
    Afr J Med Med Sci; 2012 Dec; 41(4):411-6. PubMed ID: 23672106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hemodialysis on total antioxidant status of chronic renal failure patients in government hospitals in Lagos Nigeria.
    Ajala MO; Ogunro PS; Odun A
    Niger J Clin Pract; 2011; 14(2):154-8. PubMed ID: 21860130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradialytic complications among patients on twice-weekly maintenance hemodialysis: an experience from a hemodialysis center in Eritrea.
    Raja SM; Seyoum Y
    BMC Nephrol; 2020 May; 21(1):163. PubMed ID: 32370756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance hemodialysis in patients with HIV-associated nephropathy.
    Dave MB; Shabih K; Blum S
    Clin Nephrol; 1998 Dec; 50(6):367-74. PubMed ID: 9877110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.